Accelerate the Development of Safe & Effective, Novel Drugs, Sequences & Combinatorial Therapies for Prostate Cancer

The inaugural Prostate Cancer Drug Development Summit is the only industry-led meeting uniting large pharma, biotech and pioneering academics to accelerate the clinical development of safe and effective therapies to treat prostate cancer.

With sessions on both early and advanced stages of prostate cancer (Non-Metastatic Castrate-Resistant Prostate Cancer -nmCRPC- and Metastatic Castrate-Resistant Prostate Cancer -mCRPC-), this is a conversation not to miss!

We will discuss how to tackle specific and applied drug development challenges limiting effective therapies. This includes navigating cancer heterogeneity, determining efficacy and clinically meaningful endpoints along with overcoming drug resistance

Brought directly to your home office, network with 80+ prostate cancer experts, with the likes of Amgen, Bristol-Myers Squibb, Novartis and Noxopharm, on this exclusive virtual summit and delve into the common challenges with developing effective treatments for prostate cancer patients.

Prostate Cancer Important Dates (2)

Among The Expert Speaker Faculty

Hear Why Our Attendees Are Excited About Joining This Summit:

"This meeting, which is well-timed, will discuss the cutting-edge prostate cancer drugs that will potentially advance to the clinic in the near future"

Professor, Department of Medicine & Director of Center for Cancer Drug Discovery, UTHSC

"A forum such as this which showcases the biotechnology behind the latest safe and efficacious potential treatments for mCRPC cancer is of global importance"

Chief Executive Officer & Founder, Noxopharm

Prostate Cancer Important Dates